top of page

GynOnco Group | Ginecología Oncológica en Puerto Rico | Cuidado Experto y Compasivo"

Search

A Phase II/III Study Of Paclitaxel/Carboplatin Alone Or Combined With Either Trastuzumab And Hyaluronidase-Oysk (Herceptin Hylecta) Or Pertuzumab, Trastuzumab, And Hyaluronidase-Zzxf (Phesgo) In Her2

GynOnco Group Team
Aug 16
1 min read

ree

STUDY ID: NCT05256225

STATUS: Enrolling

CONDITION: Endometrial Cancer

SPONSOR: National Cancer Institute (NCI)

FOR MORE INFORMATION VISIT: https://clinicaltrials.gov/study/NCT05256225

Recent Posts

Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005/TroFuse-005/GOG-3095)

Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005/TroFuse-005/GOG-3095)

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Can

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Can

bottom of page